Study Details Gene Signature Used by LungExpress Dx
Med BioGene Inc announced the publication of a study detailing the development and validation of the 15-gene signature used by LungExpress Dx entitled “Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small-Cell Lung Cancer”.
Read More